End-to-End Clinical Trial & CRO Services in Peru
Comprehensive GxP Solutions Tailored for Peru’s Life Sciences Industry
Peru is emerging as a pharmaceutical hub in Latin America, influenced by increasing healthcare needs and government initiatives. The national regulatory authority, DIGEMID, aligns its framework with global standards and actively engages internationally, being an ICH Observer and seeking membership in PIC/S. This trajectory supports regulatory harmonization, while the adoption of ICH E6(R3) GCP guidelines and enforcement of GMP standards according to WHO and PIC/S benchmarks shape the clinical research landscape. Also, the Peruvian government is reducing approval times for biological products to under one year and for pharmaceuticals to an average of 225 days. This improvement positions Peru as a key gateway to the Andean region and Latin America.
Zenovel offers comprehensive regulatory and scientific solutions to help clients comply with DIGEMID’s regulations and expedite access to Peru’s life sciences market.
Good Clinical Practice (GCP) Services in Peru for Regulatory-Compliant Clinical Trials
Ensuring Ethical Trials and Simplifying Peru’s GCP Compliance
Peru is advancing as a significant hub for healthcare infrastructure, varied patient demographics, and an improving regulatory framework. Pharmaceutical and biotech companies seek robust Good Clinical Practice (GCP) services that meet both international standards and local requirements. Zenovel offers specialized GCP Contract Research Organization (CRO) services in Peru, ensuring clinical trial quality, subject safety, and regulatory compliance through comprehensive monitoring, GCP audit support, and risk-based monitoring tailored to Peru’s clinical research needs.
Our team delivers GCP services in Peru, including:
- GCP consulting services are designed to strengthen sponsor oversight, improve site compliance, and enhance clinical quality systems
- Ensure alignment with ICH-GCP guidelines and DIGEMID regulatory requirements.
- Inspection readiness & sponsor oversight—mock audits, documentation control, and site/vendor compliance to ensure flawless regulatory evaluations.
- Regulatory consultation—Regulatory intelligence and operational excellence to support high-quality clinical development programs
Zenovel enhances clinical trial compliance in Peru through expert GCP support, ensuring qualityity integrity, regulatory compliance, and operational improvements.
Computer System Validation (CSV) Services in Peru for GCP & Data Integrity Compliance
Ensuring DIGEMID-Ready, Inspection-Proof CSV for GCP Compliance in Peru
Validated computerized systems are crucial for ensuring data reliability and compliance in clinical research. Zenovel offers comprehensive Computer System Validation (CSV) services in Peru for pharmaceutical and biotech companies, facilitating the validation of EDC systems, CTMS platforms, eTMF solutions, and clinical databases. Our methodologies adhere to GAMP 5 principles, ICH-GCP requirements, and DIGEMID standards, ensuring accurate and secure operation in compliance with global GCP standards.
We offer tailored clinical trial CSV services in Peru that include
- Validation planning
- IQ/OQ/PQ execution
- Risk assessments
- Audit trail verification
- Lifecycle documentation support.
- Inspection-ready System
Through CSV compliance services for clinical trials in Peru, organizations can enhance electronic record integrity, strengthen quality assurance, and mitigate regulatory risks linked to computerized systems. We support GCP-compliant system validation for sponsors expanding in Peru, ensuring reliable clinical data and successful inspections by collaborating with our regulatory experts to maintain accurate, compliant clinical research processes.
GCP Audit Services in Peru for Clinical Trial Quality Assurance
Your GCP Audit Partner for Inspection‑Ready Trials in Peru.
Maintaining quality and regulatory compliance is essential for clinical trial success. Zenovel’s GCP audit services in Peru assist sponsors, CROs, and investigator sites in identifying compliance gaps and enhancing oversight processes. The audits cover investigator sites, sponsor systems, vendors, and documentation, ensuring adherence to ICH-GCP standards, protocol requirements, and DIGEMID regulations to keep clinical studies ethical, traceable, and ready for inspection.
- Audit – site audits, sponsor audits, vendor audits, and system‑level quality reviews.
- Alignment – ICH E6(R3) guidelines, DIGEMID regulations, and WHO GCP standards.
- Key assessments—protocol adherence, informed consent processes, documentation accuracy, and data integrity.
- CAPA & readiness – CAPA development, risk‑based quality improvement, inspection readiness planning.
Companies researching in Peru need dependable GCP inspection audit services due to increasing global regulatory scrutiny. Our skilled auditors at Zenovel provide practical, inspection-focused recommendations through a blend of therapeutic expertise and regulatory knowledge.
CRO Plant Setup & Upgradation Services in Peru with Regulatory Adherence
Building a Compliant Plant from the Concept to Full Working Module in Peru
Zenovel provides professional services for establishing or upgrading GMP-compliant pharmaceutical manufacturing facilities in Peru, ensuring alignment with DIGEMID, WHO-GMP, PIC/S, and international quality standards for product quality, safety, and regulatory compliance.
At Zenovel, we offer comprehensive regulatory compliance services for both new plants and existing facilities.
Zenovel designs your plant from scratch to be a fully working module. Our services include:
- Facility planning and infrastructure development
- Cleanroom design and classification
- HVAC system design and validation
- Equipment qualification (IQ/OQ/PQ)
- Quality Management System (QMS) implementation and integration
We are also fully equipped to retrofit and upgrade your existing plants through our Existing Plant Upgradation Services.
- Facility modernization and capacity enhancement
- GMP gap assessment and remediation
- Contamination control strategies
- Process optimization and operational efficiency improvements
- Alignment with DIGEMID, PIC/S, and WHO-GMP requirements
At Zenovel, we provide end-to-end regulatory compliance solutions for both new plants and existing facilities
- Preparation for DIGEMID and international GMP inspections
- Documentation review and compliance support
- Inspection readiness assessments and corrective action planning
With Peru’s evolving regulatory landscape, Zenovel ensures your CRO is inspection‑ready, efficient, and globally competitive.
PK-Stat Review Services in Peru for Reliable Clinical Data Evaluation
Aligning Clinical Biostatistics with DIGEMID and ICH Standards
Accurate pharmacokinetic and statistical analysis is crucial for clinical development and regulatory submissions. Our PK stat review services in Peru assist sponsors in precisely evaluating clinical data, ensuring scientific reliability and regulatory compliance.
- PK/PD analysis—non‑compartmental analysis (NCA), population PK modeling, dose‑response evaluation.
- Alignment—DIGEMID expectations, ICH guidelines, and global standards (FDA, EMA).
- Data integrity—clinical biostatistics review, data compliance, submission-ready outputs.
- Regulatory support—independent review for bioequivalence studies, clinical trials, and NDA/ANDA submissions.
We offer advanced PK analysis services for clinical trials in Peru, which encompass dose proportionality assessments, bioavailability evaluations, PK/PD interpretation, and statistical reporting in compliance with global regulatory standards. Our biostatistics PK review services enhance data quality, reduce analytical risks, and support informed decision-making throughout clinical development programs, thereby ensuring the reliability and regulatory preparedness of your clinical data.
Pre-Inspection Readiness Services in Peru for GCP Compliance
Turn GCP Inspection Anxiety into Audit-Ready Assurance
Regulatory inspections affect clinical trial timelines, approvals, and organizational reputation. Zenovel offers pre-inspection readiness services in Peru for sponsors and CROs, ensuring proactive preparation for audits. Our GCP solutions assess trial documentation, operational processes, site performance, CAPA systems, and sponsor oversight frameworks, identifying compliance gaps and providing remediation strategies to enhance readiness.
- Gap assessments & mock inspections – DIGEMID‑style simulated inspections.
- Documentation reviews & quality system evaluations – informed consent, protocol adherence, data integrity, vendor oversight.
- CAPA effectiveness review & inspection response strategy.
- Staff training – inspection preparedness and real‑time response.
Our clinical trial inspection readiness services in Peru adhere to ICH-GCP standards and DIGEMID expectations, promoting operational transparency and inspection confidence during clinical development. By utilizing our GCP inspection preparedness services, organizations can enhance audit readiness, minimize findings, and improve compliance management systems, ensuring confident preparation for regulatory inspections.
Risk-Based Monitoring (RBM) Services in Peru for Efficient Clinical Oversight
Transitioning from On‑Site to Data‑Driven Monitoring with Zenovel
Clinical trials in Peru can benefit from enhanced monitoring strategies that reduce operational burdens. Zenovel offers risk-based monitoring (RBM) services focused on centralized and remote oversight, critical data review, and risk prioritization, all aligned with ICH-GCP requirements.
- Centralized monitoring & key risk indicator (KRI) development
- Site risk assessment & real‑time data review strategies
- Alignment with DIGEMID expectations and ICH E6(R3) guidelines
- Transition from routine on‑site to data‑driven, risk‑proportionate monitoring
Our centralized monitoring services in Peru enhance trial visibility, ensure protocol compliance, and facilitate early detection of site-level risks. We assist sponsors in adopting scalable RBM frameworks that optimize clinical quality and operational efficiency. Our solutions provide organizations greater control over trial performance, patient safety, and compliance management, ultimately improving clinical oversight and trial efficiency.
Sponsor Oversight Services in Peru for Clinical Governance & Compliance
Bridging global sponsor standards with Peru’s clinical research landscape
Effective sponsor oversight is crucial for accountability, regulatory compliance, and quality in clinical development. Zenovel’s services in Peru enhance governance, control over outsourced activities, vendor management, site performance monitoring, compliance tracking, and operational transparency throughout the clinical trial lifecycle.
- New plant setup—facility planning, infrastructure development, cleanroom classification, HVAC validation, equipment qualification (IQ/OQ/PQ), and QMS integration.
- Existing plant upgradation—modernization, gap closure, contamination control, process optimization, and alignment with DIGEMID, PIC/S, and WHO GMP standards.
- Regulatory readiness – preparation for and international GMP inspections.
Our GCP-compliant sponsor oversight services in Peru involve implementing governance frameworks, conducting risk assessments, reviewing audit trails, overseeing CAPA, and evaluating quality performance according to global regulatory standards. These offerings enable sponsors to enhance decision-making, ensure data integrity, and minimize operational risks in complex clinical programs, thereby strengthening governance and maintaining thorough oversight of clinical trials in Peru.
Good Manufacturing Practice (GMP) Services in Peru for Pharmaceutical Compliance
Maintaining pharmaceutical quality and regulatory compliance necessitates effective manufacturing systems that adhere to international standards. Zenovel offers GMP services in Peru, assisting pharmaceutical and biotech companies in establishing compliant manufacturing practices to ensure product safety and inspection readiness. Services include GMP audits, quality management system assessments, process validation support, and compliance consulting, aligning operations with DIGEMID requirements and global GMP standards.
- GMP audits & quality system (QMS) support – design, review, and continuous improvement.
- Deviation management, CAPA implementation & documentation control.
- Inspection readiness – gap analysis, mock TFDA inspections, and remediation planning.
- Alignment – DIGEMID requirements, WHO GMP, and global standards.
Our GMP compliance services in Peru enhance documentation systems, deviation management, CAPA effectiveness, and manufacturing quality controls. We help companies boost operational efficiency while ensuring regulatory compliance. Our GMP consulting services allow manufacturers to minimize compliance risks, enhance quality assurance, and prepare for regulatory inspections and international market standards.
GMP Audit Services in Peru for Manufacturing Quality Assurance
Guaranteeing manufacturing excellence and regulatory mastery through GMP Audit Services
Comprehensive GMP audits are vital for recognizing compliance risks and enhancing manufacturing controls. Zenovel offers GMP audit services in Peru, assisting pharmaceutical organizations in assessing their manufacturing systems against regulatory standards. Our services include evaluations of facility operations, documentation, quality assurance, deviation management, CAPA procedures, and production controls, with a focus on identifying operational gaps and providing actionable recommendations for improvement.
Our set of GMP audit services in Peru involves:
- Comprehensive GMP audits—evaluation of manufacturing facilities, quality systems (QMS), documentation control, batch records, and CAPA effectiveness.
- Supplier & internal audits—vendor quality systems, risk assessments, and root cause analysis.
- Inspection readiness—gap analysis, mock TFDA audits, and remediation planning.
- Alignment – DIGEMID requirements, WHO GMP, and global standards.
Pharma Plant Setup & Upgradation Services in Peru
Bridging global pharma standards with our Expert Plant Setup, Facility Expansion, and Technology Upgradation Services
Establishing a compliant pharmaceutical manufacturing facility necessitates meticulous planning and adherence to regulations. Zenovel offers pharma plant setup services in Peru, focusing on creating GMP-compliant operations.
We involve GMP Plant Setup & Upgradation Services in Peru, such as:
- New plant setup – facility planning, cleanroom classification, HVAC validation, equipment qualification (IQ/OQ/PQ), and QMS integration.
- Existing plant upgradation – modernization, gap closure, contamination control, process optimization.
- Alignment –DIGEMID requirements, WHO GMP, and global standards.
Zenovel integrates engineering expertise with regulatory knowledge to improve operational efficiency, mitigate compliance risks, and maintain long-term manufacturing excellence, offering trusted support for pharma plant setup and GMP upgrades in Peru.
Pre-Inspection Readiness Services for GMP Compliance in Peru
Ensuring GMP Excellence Through Pre-Inspection Preparedness
Pharmaceutical inspections necessitate thorough control over documentation, manufacturing processes, and quality systems. Zenovel provides GMP inspection readiness services in Peru to help organizations prepare for regulatory inspections by identifying quality gaps and enhancing operational controls and manufacturing compliance before inspections.
Our Pre-inspection Readiness Services for GMP Compliance in Peru include the following:
- Gap analysis – evaluation of quality systems, production processes, and documentation.
- Mock TFDA-style inspections—simulate real regulatory scrutiny.
- Audit trail & CAPA system evaluation.
- Compliance training—staff preparedness and real-time response strategies
Through our pharmaceutical inspection readiness solutions in Peru, organizations can minimize compliance risks, enhance regulatory confidence, and maintain continuous manufacturing operations that align with DIGEMID and global GMP standards.
Clinical & Scientific Expert Services in Peru for Drug Development Programs
Transforming Clinical Research into Therapeutic Success
Successful drug development hinges on scientific precision, regulatory knowledge, and strategic clinical planning. Zenovel offers clinical expert services in Peru, aiding pharmaceutical and biotech companies with specialized expertise throughout all development stages, including protocol strategy support, therapeutic consulting, endpoint evaluation, translational guidance, and clinical evidence planning tailored to global programs.
- Clinical development strategy & protocol design – tailored to DIGEMID, ICH, and global benchmarks.
- PK/PD modeling & translational science support – bridging preclinical insights to clinical outcomes.
- Biomarker strategy, endpoint selection & study optimization – enhancing trial success rates.
- Regulatory scientific consulting – for DIGEMID submissions and international filings (FDA, EMA).
Our drug development expert services in Peru enhance study design quality, strengthen scientific foundations, and optimize development pathways for regulatory success. Through clinical development consulting, sponsors receive support from experienced professionals in data interpretation, development planning, and regulatory alignment, facilitating product lifecycle management and accelerating clinical development success.
Medical & Scientific Writing Services in Peru for Regulatory Documentation
Supporting Regulatory Excellence Through Expert Scientific Writing
Accurate documentation is essential for regulatory submissions and clinical trial management. Zenovel offers medical writing services in Peru, assisting pharmaceutical and biotech companies in creating regulatory documents such as clinical study reports, protocols, and informed consent forms, meeting international standards.
Our regulatory medical writing services in Peru include:
- .Clinical study reports (CSR), protocols & investigator brochures (IB)
- Informed consent forms (ICF) & CTD/eCTD modules
- Pharmacovigilance documents & clinical summaries
- Full alignment with ICH, DIGEMID, and global regulatory standards
Our regulatory medical writing services in Peru guarantee consistency, scientific accuracy, and compliance with ICH-GCP guidelines and DIGEMID expectations. We assist sponsors in creating high-quality documentation that enhances submission efficiency and readiness for review, ensuring traceable and audit-ready documentation throughout clinical development programs.
Preclinical Support Services in Peru for Early Drug Development
Transforming Scientific Discoveries into Development Opportunities
Reliable preclinical research is crucial for developing strong scientific evidence before clinical trials. Zenovel provides preclinical support services in Peru, aiding pharmaceutical and biotech companies in expediting early-stage drug development. Our offerings include toxicology support, pharmacology studies, ADME analysis, safety assessments, and IND-enabling research strategies tailored to specific development goals.
Our Preclinical Support Services in Peru Include:
- In vitro & in vivo studies – toxicology assessment, PK/PD analysis, and safety pharmacology.
- Bioanalytical support & translational research – bridging discovery to clinical application.
- Lead compound optimization & risk identification – improving candidate selection.
- Regulatory documentation—aligned with DIGEMID, ICH, and global standards (FDA, EMA).
Our early-stage drug development services in Peru aim to generate reliable preclinical data essential for regulatory submissions, candidate selection, and risk reduction before clinical trials. Through our preclinical CRO services, organizations benefit from experienced scientific support that enhances research quality, translational relevance, and regulatory preparedness.
Regulatory Affairs & Compliance Services in Peru for Global Approvals
Accelerating Product Approvals from Peru to Global Markets
Navigating international product launches necessitates strategic regulatory planning that conforms to DIGEMID requirements and local expectations. Effective submission strategies should consider cross-regional compliance to ensure success in both Peru and global markets. Zenovel offers Regulatory Affairs & Compliance Services in Peru to assist pharmaceutical, biotechnology, and healthcare companies in obtaining efficient global approvals.
Our Regulatory Affairs Services in Peru Include:
- Regulatory strategy & gap analysis – tailored to DIGEMID, FDA, EMA, and WHO requirements.
- CTD/eCTD dossier preparation – IND/CTA, NDA/BLA, and post-approval maintenance.
- Labeling compliance & regulatory intelligence – supporting lifecycle management across multiple markets.
- Submission coordination – ensuring accuracy, consistency, and timely communication with regulatory authorities.
We collaborate with your teams to reduce submission risks, speed up market access, and ensure regulatory compliance during the product lifecycle. Our experts offer strategic guidance for navigating Peru’s regulatory environment while supporting global development and commercialization goals.
Dossier Due Diligence Services in Peru for Regulatory Submission Accuracy
Ensuring Regulatory Confidence Through Dossier Review.
Regulatory submissions must be accurate and compliant to prevent review delays. Zenovel offers dossier due diligence services in Peru, focusing on CTD and eCTD review, consistency verification, scientific data validation, and documentation quality assessment.
Our Dossier Due Diligence Services in Peru Include the Following:
- CTD/eCTD gap analysis – missing evidence, contradictions, formatting inconsistencies.
- Clinical & CMC data alignment – ensuring coherence across modules.
- ICH guideline compliance – module integration and submission risk assessment.
- Actionable remediation plans – to strengthen dossier quality and approval confidence
Our pharmaceutical dossier review services in Peru identify regulatory gaps, formatting issues, missing data, and compliance risks affecting approval timelines. Our regulatory dossier validation services enhance submission quality, data traceability, and overall regulatory readiness, ensuring accuracy and compliance for effective submissions.
eCTD Compilation Services in Peru for Global Regulatory Submissions
Building Compliant eCTD Dossiers for Worldwide Market Access
Electronic submissions are essential for pharmaceutical approvals globally. Zenovel offers eCTD compilation services in Peru, aiding pharmaceutical and biotech companies in preparing compliant submissions for regulatory authorities. Services include dossier formatting, lifecycle management, submission publishing, hyperlink validation, and CTD-to-eCTD conversion, all in line with DIGEMID and global regulations.
- Document formatting & module‑wise structuring – aligning with DIGEMID, ICH, and global guidelines.
- Hyperlinking, validation & publishing – ensuring technical acceptance by regulatory portals.
- CTD to eCTD conversion & lifecycle management – for IND, NDA, ANDA, and BLA filings.
- Submission readiness – full compliance with evolving eCTD, ICH, and PIC/S requirements.
Our regulatory eCTD services in Peru focus on document consistency and technical accuracy to ensure submission readiness. We assist organizations with module organization, quality control, and validation reviews to reduce errors and delays. Our eCTD submission services help sponsors streamline operations, enhance approval timelines, and manage global product registrations efficiently. Simplify global submissions with our compliant eCTD compilation services in Peru.
Environmental Risk Assessment Services in Peru for Pharmaceutical Compliance
Supporting Sustainable Pharmaceutical Development with ERA Expertise
Environmental compliance is vital in pharmaceutical development and manufacturing. Zenovel offers services in Peru to help organizations assess their environmental impact while ensuring regulatory and sustainability compliance. Our services include pharmaceutical waste evaluation, chemical exposure analysis, ecological impact assessments, and support for environmental documentation aligned with regulations.
- Phase I & Phase II environmental assessments – initial and refined risk evaluations.
- PEC/PNEC calculations & exposure modeling – predicting environmental concentrations and effects.
- Ecotoxicity evaluation & regulatory dossier preparation – aligned with submission requirements.
- Integration with global submission strategies – for DIGEMID, EMA, FDA, and WHO.
Our pharmaceutical environmental risk assessment solutions in Peru help organizations identify and mitigate environmental risks linked to manufacturing and product handling. We enhance operational sustainability and compliance readiness while improving environmental governance and regulatory submissions throughout the product lifecycle. Ensure responsible operations with our expert services.
EU QP Support Services in Peru for Batch Release & GMP Compliance
Supporting Pharmaceutical Excellence with End-to-End EU QP Services
Accessing European pharmaceutical markets demands adherence to EU GMP standards and Qualified Person oversight. Zenovel offers QP services in Peru to assist pharmaceutical manufacturers with compliant batch release processes, including batch documentation review, deviation assessment, CAPA evaluation, and GMP compliance verification, in line with EU Annex 16 requirements.
- Batch record review & GMP compliance verification – against EU GMP and PIC/S standards.
- Deviation assessment & quality documentation evaluation.
- Coordination with EU Qualified Persons—for final certification and release.
- Alignment with EU GMP Annex 16 and global regulatory expectations.
- Support under DIGEMID export guidelines and WHO GMP/PIC/S frameworks.
Our EU batch release support services in Peru assist organizations in enhancing traceability, improving manufacturing quality assurance, and ensuring complete regulatory documentation prior to product certification. Our GMP batch release compliance solutions help pharmaceutical companies mitigate export risks, enhance inspection readiness, and consistently meet European regulatory standards, facilitating compliant EU batch release and global market access with expert QP support.
Regulatory Gap Analysis Services for Compliance Readiness in Brazil
We assist you with Regulatory Gap Analysis and Inspection Readiness in Brazil.
Identifying compliance gaps early is essential for effective clinical development, manufacturing, and obtaining ANVISA approvals. Our regulatory gap analysis services assist in fortifying systems before inspections.
Zenovel offers detailed gap analysis services tailored for the pharmaceutical industry in Brazil, addressing regulatory compliance and market needs.
- Evaluation of documentation, processes & quality systems
- Alignment with GCP, GMP, and global regulatory standards
- Assessment of SOPs, audit trails, CAPA systems & regulatory files
- Clear, actionable remediation strategies for inspection readiness
Zenovel assists sponsors, CROs, and manufacturers in minimizing approval delays and compliance risks through evidence-based, structured assessments, fostering regulatory confidence.
Accelerate your global approvals with expert regulatory support.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
